Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private

biopharmaceutical A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, t ...

company based in

San Diego, California San Diego ( , ) is a city on the Pacific coast of Southern California, adjacent to the Mexico–United States border. With a population of over 1.4 million, it is the List of United States cities by population, eighth-most populous city in t ...

. It was founded in 2008 by Osman Kibar."Forbes Profile: Osman Kibar"
"

Forbes ''Forbes'' () is an American business magazine founded by B. C. Forbes in 1917. It has been owned by the Hong Kong–based investment group Integrated Whale Media Investments since 2014. Its chairman and editor-in-chief is Steve Forbes. The co ...

" Samumed's products in development target novel components of the

Wnt signaling pathway In cellular biology, the Wnt signaling pathways are a group of signal transduction pathways which begin with proteins that pass signals into a cell through cell surface receptors. The name Wnt, pronounced "wint", is a portmanteau created from the ...

.Herper, Matthe
"Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging"
"

", May 10, 2016Ramsey, Lydia
"A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles"
"

Business Insider ''Business Insider'' (stylized in all caps: BUSINESS INSIDER; known from 2021 to 2023 as INSIDER) is a New York City–based multinational financial and business news website founded in 2007. Since 2015, a majority stake in ''Business Inside ...

", April 2, 2017Lee, Yoolim
"Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist"
"Bloomberg", February 9, 2017 The company focuses on potential treatments for several diseases; its

osteoarthritis Osteoarthritis is a type of degenerative joint disease that results from breakdown of articular cartilage, joint cartilage and underlying bone. A form of arthritis, it is believed to be the fourth leading cause of disability in the world, affect ...

program is its most advanced.Jackson, Mandy
"ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III"
"Informa Scrip", November 8, 2017"

References

Pharmaceutical companies of the United States Companies based in San Diego Pharmaceutical companies 2008 establishments in California American companies established in 2008 {{US-company-stub